Lexaria Bioscience Corp. Earnings Per Share Diluted

Quick Answer

Lexaria Bioscience Corp. reported Earnings Per Share Diluted of $0.66 (loss) per share for the year ending 2025.

  • Lexaria Bioscience Corp. showed a decrease of -40.4% in Earnings Per Share Diluted from 2024 to 2025.
  • This data is from Lexaria Bioscience Corp.'s annual report (Form 10-K), filed with the SEC on November 28, 2025.
  • XBRL data for this metric is available from 2010 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 5 years of available data (2010 to 2025), Lexaria Bioscience Corp.'s Earnings Per Share Diluted has declined by 1,550.0%.
  • Historical annual values: Fiscal year 2025: $0.66 (loss) per share | Fiscal year 2024: $0.47 (loss) per share | Fiscal year 2023: $1.01 (loss) per share | Fiscal year 2011: $0.04 (loss) per share | Fiscal year 2010: $0.04 (loss) per share.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: